 Piperacillin
"Piperacillin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
| Descriptor ID |
D010878
|
| MeSH Number(s) |
D02.065.589.099.750.750.050.650 D02.886.108.750.750.050.650 D03.438.260.825.750.050.650 D03.605.084.737.750.050.650 D04.075.080.875.099.221.750.750.050.650
|
| Concept/Terms |
Piperacillin Sodium- Piperacillin Sodium
- Sodium, Piperacillin
- Piperacillin Monosodium Salt
- Monosodium Salt, Piperacillin
- Salt, Piperacillin Monosodium
Pipracil- Pipracil
- Wyeth Brand of Piperacillin Sodium
- Lederle Brand of Pipracillin Sodium
- Pipril
Pipera-hameln- Pipera-hameln
- Pipera hameln
- Astrapin Brand of Piperacillin Sodium
AB-Piperacillin- AB-Piperacillin
- AB Piperacillin
- Piperacillin curasan
- curasan Brand of Piperacillin Sodium
Pipcil- Pipcil
- AHP Brand of Piperacillin Sodium
|
Below are MeSH descriptors whose meaning is more general than "Piperacillin".
Below are MeSH descriptors whose meaning is more specific than "Piperacillin".
This graph shows the total number of publications written about "Piperacillin" by people in this website by year, and whether "Piperacillin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Piperacillin" by people in Profiles.
-
Pais GM, Liu J, Avedissian SN, Hiner D, Xanthos T, Chalkias A, d'Aloja E, Locci E, Gilchrist A, Prozialeck WC, Rhodes NJ, Lodise TP, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model. J Antimicrob Chemother. 2020 05 01; 75(5):1228-1236.
-
Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
-
Zakrison TL, Hille DA, Namias N. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam. Surg Infect (Larchmt). 2012 Feb; 13(1):38-42.
-
Hebert C, Villaran R, Tolentino J, Best L, Boonlayangoor S, Pitrak D, Lin M, Weber SG. Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains. Scand J Infect Dis. 2010 Jul; 42(6-7):506-9.
-
Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect. 2008 Jan; 14 Suppl 1:181-4.
-
Gavin PJ, Suseno MT, Thomson RB, Gaydos JM, Pierson CL, Halstead DC, Aslanzadeh J, Brecher S, Rotstein C, Brossette SE, Peterson LR. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother. 2006 Jun; 50(6):2244-7.
-
Lin MY, Carmeli Y, Zumsteg J, Flores EL, Tolentino J, Sreeramoju P, Weber SG. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother. 2005 Nov; 49(11):4555-60.
-
Roy S, Higareda I, Angel-Muller E, Ismail M, Hague C, Adeyi B, Woods GL, Teppler H. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol. 2003; 11(1):27-37.
-
Anders RJ, Lau A, Sharifi R, Lee M. Comparison of EMIT versus bioassay to evaluate inactivation of tobramycin by piperacillin. Ther Drug Monit. 1987 Dec; 9(4):472-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|